Financials
- Market Capitalization 2.41 B
- Employee 540
- Founded 2008
- CEO N/A
- Website www.agios.com
- Headquarter Delaware, United States
- FIGI BBG000QY4ZD0
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.82
Rapporto prezzo/fatturato
29.21
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1845 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.91 USD | -5.17% | -4.16% | +13.13% | +10.11% | 2.52 B USD | ||
| 1865 | VCEL Vericel Corporation - Common Stock | 47.49 USD | +1.04% | +0.87% | +25.40% | +30.65% | 2.43 B USD | ||
| 1885 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.71 USD | -1.52% | -5.65% | +32.81% | +102.59% | 2.36 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.62 USD | -1.10% | -9.21% | +59.75% | +540.61% | 2.35 B USD |